Welcome to CD BioSciences
Banner

Pathogenic Bacteria Screening Service

Pathogenic Bacteria Screening Service

Pathogenic bacteria proliferate under suitable conditions. By invading human tissues and organs, they cause lesions that put human health at risk to varying degrees. In the most severe cases, will lead to death. In clinical practice, humans are protected by the use of antibiotics as well as other antibacterial drugs to kill overgrown pathogenic bacteria.

With the overuse of antibiotics, the emergence of drug-resistant bacteria has become a major threat to human health. The search for new antibacterial drugs is imminent. CD BioSciences provides an advanced technology platform for pathogenic bacteria screening service, hoping to rapidly detect bacteria that are inhibitory to pathogenic bacteria. Our MicroScanTM technology platform is development to meet customer's personalized customization needs.

Pathogenic Bacteria Screening Service

Common Pathogenic Bacteria and Hazards

There are many pathogenic bacteria that cause illness in humans. In clinical practice, the following types of bacterial infections are more common and can cause a variety of clinical symptoms.

StreptococcusStreptococcus StaphylococcusStaphylococcus PseudomonasPseudomonas
Streptococcus are part of the normal microbiota, but can become pathogenic under certain conditions. For example, Streptococcus agalactiae and Streptococcus pneumoniae can cause skin infections, sepsis, pneumonia, and meningitis. Staphylococcus are a common group of pathogens. They can cause food poisoning, skin as well as wound infections. In addition, severe infections with Staphylococcus aureus can cause inflammatory conditions such as meningitis, enteritis, and endocarditis. Pseudomonas is one of the major pathogens of hospital-acquired infections. Pseudomonas aeruginosa infections occur in clinical practice in burns, acute leukemia, organ transplant patients, and intravenous drug users. Most of the infections are located in moist places.
MycobacteriumMycobacterium EnterococcusEnterococcus OthersOthers
Mycobacterium can be divided into Mycobacterium tuberculosis, Mycobacterium leprae and Mycobacterium non-tuberculosis. The first two types of bacteria are the causative agents of tuberculosis and leprosy. The latter causes lesions in a variety of tissues or joints, etc. Enterococcus are the second most common pathogen causing nosocomial infections. For example, Enterococcus faecalis and Enterococcus faecium can cause urinary tract infections, skin and soft tissue infections, and life-threatening abdominal infections, sepsis, endocarditis, and meningitis. In addition to the common clinical pathogens, there are many opportunistic pathogenic bacteria. For example, Enterobacteria can cause multiple infections throughout the body and Klebsiella can easily invade people with low immunity.

Pathogenic Bacteria Screening Services

Inappropriate use of antibiotics and the continuous evolution of bacteria have led to an increase in drug-resistant strains. The search for new antibacterial drugs is an urgent problem for mankind. The traditional method of discovering antibiotics through inhibition is no longer able to keep up with the development of drug-resistant bacteria. Therefore, faster and more convenient methods must be found to discover new antibiotics.

We provide MicroScanTM platform for pathogenic bacteria screening services, which allows large-scale screening of pathogen-inhibiting bacteria, thus providing a faster service for finding new drugs.

Features of Services

  • Perfect Experimental Conditions
    CD BioSciences has a rich resource of pathogenic bacteria strains and a professional laboratory that strongly supports scientific research.
  • Fast Delivery
    We guarantee to submit your results within your expected time.
  • Comprehensive Service
    Professional pre-sales, in-sales and after-sales service to answer your questions in detail.

CD BioSciences is committed to providing professional and efficient service to our customers around the world. As a pioneer in biotechnology, CD BioSciences has grown into one of the largest independent biotechnology companies in the world. If you would like more information, please contact us.

For research use only. Not for clinical use.

Online Inquiry